부산대학교 도서관

Oza, Amit M ; Cibula, David ; Benzaquen, Ana Oaknin ; Poole, Christopher ; Mathijssen, Ron H J ; Sonke, Gabe S ; Colombo, Nicoletta ; Špaček, Jiří ; Vuylsteke, Peter ; Hirte, Holger ; Mahner, Sven ; Plante, Marie ; Schmalfeldt, Barbara ; Mackay, Helen ; Rowbottom, Jacqui ; Lowe, Elizabeth S ; Dougherty, Brian ; Barrett, J Carl ; Friedlander, Michael

In Lancet Oncology January 2015 16(1):87-97

Frigault, Melanie M; Barrett, J Carl

In Current Opinion in Pharmacology August 2014 17:81-86

Ledermann, Jonathan ; Harter, Philipp ; Gourley, Charlie ; Friedlander, Michael ; Vergote, Ignace ; Rustin, Gordon ; Scott, Clare L ; Meier, Werner ; Shapira-Frommer, Ronnie ; Safra, Tamar ; Matei, Daniela ; Fielding, Anitra ; Spencer, Stuart ; Dougherty, Brian ; Orr, Maria ; Hodgson, Darren ; Barrett, J Carl ; Matulonis, Ursula

In Lancet Oncology July 2014 15(8):852-861

Lavigne, Jackie A ; Baer, David J ; Wimbrow, Heather H ; Albert, Paul S ; Brown, Ellen D ; Judd, Joseph T ; Campbell, William S ; Giffen, Carol A ; Dorgan, Joanne F ; Hartman, Terryl J ; Barrett, J Carl ; Hursting, Stephen D ; Taylor, Philip R

In The American Journal of Clinical Nutrition February 2005 81(2):503-507

Arango-Argoty G; Oncology R&D, AstraZeneca, Waltham, MA, USA. gustavo.arango@astrazeneca.com.; Haghighi M; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Sun GJ; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Choe EY; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Markovets A; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Barrett JC; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Lai Z; Oncology R&D, AstraZeneca, Waltham, MA, USA.; Jacob E; Oncology R&D, AstraZeneca, Waltham, MA, USA. etai.jacob@astrazeneca.com.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Carney, Sara A ; Tahara, Hidetoshi ; Swartz, Carol D ; Risinger, John I ; He, Hong ; Moore, Alicia B ; Haseman, Joseph K ; Barrett, J Carl ; Dixon, Darlene

In Laboratory Investigation 1 June 2002 82(6):719-728

Bass C; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom. cher@panakeia.ai.; Ntelemis F; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Schmidt J; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Wolf S; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Geraldes A; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Mehrotra D; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Singhal S; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Kumar N; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Marcia A; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Bennett N; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Maiques O; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom.; Hyde M; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Mistry B; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Rogerson G; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Cummings M; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Freer C; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Walsh E; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Department of Histopathology, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.; Salto-Tellez M; Queen's University Belfast, School of Medicine, Dentistry and Biomedical Sciences, Patrick G Johnston Centre for Cancer Research, 97 Lisburn Rd, Belfast, BT9 7AE, Belfast, United Kingdom.; Integrated Pathology Unit, Institute of Cancer Research, London, United Kingdom.; Loughrey M; Queen's University Belfast, School of Medicine, Dentistry and Biomedical Sciences, Patrick G Johnston Centre for Cancer Research, 97 Lisburn Rd, Belfast, BT9 7AE, Belfast, United Kingdom.; Department of Cellular Pathology, Belfast Health and Social Care Trust, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, United Kingdom.; Um IH; School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, United Kingdom.; Harrison DJ; School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, United Kingdom.; Clarkson R; Wales Cancer Biobank, Cardiff University, 2nd Floor, Room 2LB4 64, A Block, UHW Main Building, Heath Park, Cardiff, CF14 4XN, United Kingdom.; Blackwood J; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; School of Medicine, University of St Andrews, North Haugh, St Andrews, KY16 9TF, United Kingdom.; Barrett JC; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Kather JN; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307, Dresden, Germany.; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; Orsi NM; Women's Health Research Group, Leeds Institute of Cancer & Pathology, Wellcome Trust Brenner Building, St James's University Hospital, University of Leeds, Beckett Street, Leeds, LS9 7TF, United Kingdom.; Department of Histopathology, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.; Pandya P; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.; Arslan S; Panakeia Technologies, Salisbury House, Station Road, CB1 2LA, Cambridge, United Kingdom.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101731738 Publication Model: Electronic Cited Medium: Internet ISSN: 2398-6352 (Electronic) Linking ISSN: 23986352 NLM ISO Abbreviation: NPJ Digit Med Subsets: PubMed not MEDLINE

Xie M; Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA.; Vuko M; Computational Pathology, AstraZeneca, Munich, Germany.; Saran S; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.; Liu S; Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA.; Chambers AG; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Baakza H; Translational Pathology, Oncology R&D, AstraZeneca, Cambridge, UK.; Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.; Ng F; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK.; Gay CM; Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cardnell RJ; Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Segerer FJ; Computational Pathology, AstraZeneca, Munich, Germany.; Andoni A; Translational Pathology, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Rodriguez-Canales J; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Waring PM; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK.; Schick M; Computational Pathology, AstraZeneca, Munich, Germany.; Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA, USA.; Current affiliation: University of North Carolina, Chapel Hill, NC, USA.; Byers LA; Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fabbri G; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA, USA. giulia.fabbri@astrazeneca.com.

Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Markovets A; Oncology Data Science and AI, Oncology R&D, AstraZeneca, Boston, MA.; Merino Vega D; Translational Medicine, Cancer Biomarker Development, Oncology R&D, AstraZeneca, Gaithersburg, MD.; Abbosh C; Oncology R&D Strategy, AstraZeneca, Cambridge, United Kingdom.; Quinn K; Guardant Health, Palo Alto, CA.; Chang K; Guardant Health, Palo Alto, CA.; Wienke S; Guardant Health, Palo Alto, CA.; Hartmaier R; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA.; Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA.; Hodgson D; Translational Medicine, Cancer Biomarker Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Galan-Cobo A; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vokes NI; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qian Y; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Molkentine D; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ramkumar K; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Paula AG; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pisegna M; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McGrail DJ; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.; Poteete A; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cho S; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do MT; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Karimi A; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kong Y; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Solanki A; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Karmokar A; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Floc'h N; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Hughes A; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Sargeant R; Imaging Sciences, CPSS, AstraZeneca, Cambridge, UK.; Young L; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Shen L; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kar G; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Keshvani C; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arrechedera C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hernandez S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Schlacher K; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Iyer S; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA.; Conway J; Oncology Data Science, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Keddar MR; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK.; Milo M; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, UK.; de Toma I; Early Oncology, Oncology R&D, AstraZeneca, Barcelona, Spain.; Critchlow SE; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA.; Cosaert J; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Lau A; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Valge-Archer V; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Byers LA; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Barry ST; Early Oncology R&D, AstraZeneca, Cambridge, UK.; Heymach JV; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jheymach@mdanderson.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Xie, Mingchao; Vuko, Miljenka; Rodriguez-Canales, Jaime; Zimmermann, Johannes; Schick, Markus; O'Brien, Cathy; Paz-Ares, Luis; Goldman, Jonathan W; Garassino, Marina Chiara; Gay, Carl M; Heymach, John V; Jiang, Haiyi; Barrett, J Carl; Stewart, Ross A; Lai, Zhongwu; Byers, Lauren A; Rudin, Charles M; Shrestha, Yashaswi

Mol Cancer
Molecular Cancer, Vol 23, Iss 1, Pp 1-17 (2024)

Petersen, David; Chandramouli, GVR; Geoghegan, Joel; Hilburn, Joanne; Paarlberg, Jonathon; Chang Hee Kim; Munroe, David; Gangi, Lisa; Han, Jing; Puri, Raj; Staudt, Lou; Weinstein, John; Barrett, J Carl; Green, Jeffrey; Kawasaki, Ernest S

BMC Genomics. 2005, Vol. 6, p63-14. 14p. 1 Diagram, 4 Charts, 6 Graphs.

Yawata, Toshio; Kamino, Hiroki; Kugoh, Hiroyuki; Katoh, Motonobu; Nomura, Nobuo; Oishi, Michio; Horikawa, Izumi; Barrett, J Carl; Oshimura, Mitsuo

Oncogene. 1/16/2003, Vol. 22 Issue 2, p281. 10p.

Nishimoto, Arata; Miura, Norimasa; Horikawa, Izumi; Kugoh, Hiroyuki; Murakami, Yoshinori; Hirohashi, Setsuo; Kawasaki, Hironaka; Gazdar, Adi F; Shay, Jerry W; Barrett, J Carl; Oshimura, Mitsuo

Oncogene. 2/15/2001, Vol. 20 Issue 7, p828. 8p.

Hardaker EL; Oncology R&D, AstraZeneca, Cambridge, UK.; Sanseviero E; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Karmokar A; Oncology R&D, AstraZeneca, Cambridge, UK.; Taylor D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Milo M; Oncology R&D, AstraZeneca, Cambridge, UK.; Michaloglou C; Oncology R&D, AstraZeneca, Cambridge, UK.; Hughes A; Oncology R&D, AstraZeneca, Cambridge, UK.; Mai M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; King M; Oncology R&D, AstraZeneca, Cambridge, UK.; Solanki A; Oncology R&D, AstraZeneca, Cambridge, UK.; Magiera L; Oncology R&D, AstraZeneca, Cambridge, UK.; Miragaia R; Oncology R&D, AstraZeneca, Cambridge, UK.; Kar G; Oncology R&D, AstraZeneca, Cambridge, UK.; Standifer N; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Tempest Therapeutics, Brisbane, CA, USA.; Surace M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Gill S; Oncology R&D, AstraZeneca, Cambridge, UK.; Peter A; Oncology R&D, AstraZeneca, Cambridge, UK.; Talbot S; Oncology R&D, AstraZeneca, Cambridge, UK.; Tohumeken S; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Fryer H; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Mostafa A; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Mulgrew K; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Lam C; Oncology R&D, AstraZeneca, Cambridge, UK.; Hoffmann S; Imaging and Data Analytics, AstraZeneca, Cambridge, UK.; Sutton D; Imaging and Data Analytics, AstraZeneca, Cambridge, UK.; Carnevalli L; Oncology R&D, AstraZeneca, Cambridge, UK.; Calero-Nieto FJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Jones GN; Oncology R&D, AstraZeneca, Cambridge, UK.; Pierce AJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Crescendo Biologics Limited, Cambridge, UK.; Wilson Z; Oncology R&D, AstraZeneca, Cambridge, UK.; Campbell D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Nyoni L; Oncology R&D, AstraZeneca, Cambridge, UK.; Martins CP; Oncology R&D, AstraZeneca, Cambridge, UK.; Baker T; CPSS AST, AstraZeneca, Cambridge, UK.; Serrano de Almeida G; CPSS AST, AstraZeneca, Cambridge, UK.; Ramlaoui Z; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Bidar A; CPSS, Imaging, AstraZeneca, Gothenburg, Sweden.; Phillips B; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.; Boland J; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Iyer S; Oncology R&D, AstraZeneca, Boston, MA, USA.; Barrett JC; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Loembé AB; Early Clinical Development, AstraZeneca, Oss, the Netherlands.; Fuchs SY; Department of Biomedical Sciences, School of Veterinary Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA.; Duvvuri U; UPMC Department of Otolaryngology and UPMC Hillman Cancer Center, 200 Lothrop St. Suite 500, Pittsburg, PA, 15213, USA.; Lou PJ; National Taiwan University Hospital, No. 7, Chung Shan S. Rd. (Zhongshan S. Rd.), Zhongzheng Dist., Taipei City, 10002, Taiwan.; Nance MA; VA Pittsburgh Healthcare System, University Drive C, Pittsburg, PA, 15240, USA.; Gomez Roca CA; Institut Claudius Regaud-Cancer Comprehensive Center, 1 Avenue Irene Joliot-Curie, IUCT-O, Toulouse, 31059 Cedex 9, France.; Cadogan E; Oncology R&D, AstraZeneca, Cambridge, UK.; Critichlow SE; Oncology R&D, AstraZeneca, Cambridge, UK.; Fawell S; Oncology R&D, AstraZeneca, Boston, MA, USA.; Cobbold M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Dean E; Oncology R&D, AstraZeneca, Cambridge, UK.; Valge-Archer V; Oncology R&D, AstraZeneca, Cambridge, UK.; Lau A; Oncology R&D, AstraZeneca, Cambridge, UK.; Gabrilovich DI; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. dmitry.gabrilovich@astrazeneca.com.; Barry ST; Oncology R&D, AstraZeneca, Cambridge, UK. simon.t.barry@astrazeneca.com.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Johnson M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Cambridge, UK.; Serra Traynor C; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Cambridge, UK.; Vishwanathan K; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Boston, Massachusetts, USA.; Overend P; Oncology Biometrics, Oncology, R&D, AstraZeneca, Cambridge, UK.; Hartmaier R; Translational Medicine, Oncology, R&D, AstraZeneca, Boston, Massachusetts, USA.; Markovets A; Translational Medicine, Oncology, R&D, AstraZeneca, Boston, Massachusetts, USA.; Chmielecki J; Translational Medicine, Oncology, R&D, AstraZeneca, Boston, Massachusetts, USA.; Mugundu GM; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Boston, Massachusetts, USA.; Barrett JC; Translational Medicine, Oncology, R&D, AstraZeneca, Boston, Massachusetts, USA.; Tomkinson H; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Cambridge, UK.; Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, Georgia, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Hollis RL; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK. Electronic address: robb.hollis@ed.ac.uk.; Churchman M; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Grimes GR; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Meynert AM; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Gautier P; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; McMahon L; Precision Medicine Scotland (PMS-IC), Queen Elizabeth University Hospital, Glasgow, UK.; Sherwood K; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK; Department of Oncology, University of Oxford, Oxford, UK; Edinburgh Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Oswald AJ; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Croy I; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Ferguson M; Department of Oncology, NHS Tayside, Dundee, UK.; Martin CW; The Simpson Centre for Reproductive Health, Royal Infirmary Edinburgh, Edinburgh, UK.; McGoldrick T; Department of Oncology, Aberdeen Royal Infirmary, Aberdeen, UK.; McPhail N; Department of Oncology, Raigmore Hospital, NHS Highland, Inverness, UK.; Creedon H; The Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.; Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA, USA.; March R; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK.; Dougherty BA; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, MA, USA.; Roxburgh P; Cancer Research UK Scotland Centre, School of Cancer Sciences, Glasgow, UK; Beatson West of Scotland Cancer Centre, Glasgow, UK.; Ewing A; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK; Edinburgh Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Herrington CS; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Semple CA; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Gourley C; The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Cani, Andi K; Dolce, Emily M; Darga, Elizabeth P; Hu, Kevin; Liu, Chia-Jen; Pierce, Jackie; Bradbury, Kieran; Kilgour, Elaine; Aung, Kimberly; Schiavon, Gaia; Carroll, Danielle; Carr, T Hedley; Klinowska, Teresa; Lindemann, Justin; Marshall, Gayle; Rowlands, Vicky; Harrington, Elizabeth A; Barrett, J Carl; Sathiyayogan, Nitharsan; Morrow, Christopher; Sero, Valeria; Armstrong, Anne C; Baird, Richard; Hamilton, Erika; Im, Seock-Ah; Jhaveri, Komal; Patel, Manish R; Dive, Caroline; Tomlins, Scott A; Udager, Aaron M; Hayes, Daniel F; Paoletti, Costanza

Mol Oncol
Molecular Oncology, Vol 16, Iss 10, Pp 1969-1985 (2022)

Devereux, Theodora R; Anna, Colleen H; Foley, Julie F; White, Catherine M; Sills, Robert C; Barrett, J Carl

Oncogene. 8/19/99, Vol. 18 Issue 33, p4726. 8p. 1 Color Photograph, 1 Black and White Photograph, 2 Diagrams, 3 Charts.

Matsuda, Takao; Sasaki, Masahiro; Kato, Hidenori; Yamada, Hideto; Cohen, Maurice; Barrett, J Carl; Oshimura, Mitsuo; Wake, Norio

Oncogene. 12/04/97, Vol. 15 Issue 23, p2773. 9p. 5 Black and White Photographs, 2 Charts, 3 Graphs.